Cargando…
High-performance CRISPR-Cas12a genome editing for combinatorial genetic screening
CRISPR-based genetic screening has revolutionized cancer drug target discovery, yet reliable, multiplex gene editing to reveal synergies between gene targets remains a major challenge. Here, we present a simple and robust CRISPR-Cas12a-based approach for combinatorial genetic screening in cancer cel...
Autores principales: | Gier, Rodrigo A., Budinich, Krista A., Evitt, Niklaus H., Cao, Zhendong, Freilich, Elizabeth S., Chen, Qingzhou, Qi, Jun, Lan, Yemin, Kohli, Rahul M., Shi, Junwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359328/ https://www.ncbi.nlm.nih.gov/pubmed/32661245 http://dx.doi.org/10.1038/s41467-020-17209-1 |
Ejemplares similares
-
Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework
por: Evitt, Niklaus H., et al.
Publicado: (2015) -
A combinatorial CRISPR-Cas12a attack on HIV DNA
por: Fan, Minghui, et al.
Publicado: (2022) -
Improved genome editing by an engineered CRISPR-Cas12a
por: Ma, Enbo, et al.
Publicado: (2022) -
Engineering of CRISPR-Cas12b for human genome editing
por: Strecker, Jonathan, et al.
Publicado: (2019) -
CRISPR-Cas12a-Assisted Genome Editing in Amycolatopsis mediterranei
por: Zhou, Yajuan, et al.
Publicado: (2020)